Trials / Completed
CompletedNCT01025518
DAHANCA 25A: Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following Radiotherapy in Head and Neck Cancer Patients
A Randomized Trial Evaluating Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following Radiotherapy in Head and Neck Cancer Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Danish Head and Neck Cancer Group · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate whether resistance training in combination with dietary supplementation is tolerable among head and neck cancer patients and to evaluate the possible effect on muscle mass, strength and functional capacity.
Detailed description
Head and neck cancer patients experience a significant loss of muscle mass following radiotherapy treatment due to cachexia and dysphagia. This negatively affects muscle strength and functional capacity. Studies on healthy individuals and various groups of patients show that resistance training in combination with protein and creatine ingestion is an effective means of increasing muscle mass, strength and functional capacity. Thus the aim is to investigate the following: * is resistance training and dietary supplements tolerable among head and neck cancer patients * the effect of the intervention on muscle mass, strength and functional capacity
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Resistance training | 12 weeks of resistance training in combination with protein and creatine or placebo ingestion |
| DIETARY_SUPPLEMENT | Protein and creatine | 30 g of protein with each training session, 5 g of creatine pr day |
| DIETARY_SUPPLEMENT | Placebo | Maltodextrine |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2009-12-03
- Last updated
- 2016-11-29
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01025518. Inclusion in this directory is not an endorsement.